{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:13:05Z","timestamp":1783969985108,"version":"3.55.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmech.2018.08.061","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T19:19:29Z","timestamp":1535397569000},"page":"1081-1095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1566-2683","authenticated-orcid":false,"given":"Chuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-460X","authenticated-orcid":false,"given":"Yi-Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Cheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.08.061_bib1","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/acs.jmedchem.7b01634","article-title":"Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE) in\u00a0vitro and in\u00a0vivo","volume":"61","author":"Parmar","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib2","doi-asserted-by":"crossref","first-page":"O796","DOI":"10.1111\/1469-0691.12624","article-title":"A\u00a012-year survey of methicillin-resistant Staphylococcus Aureus infections in Greece: ST80-IV epidemic?","volume":"20","author":"Drougka","year":"2014","journal-title":"Clin. Microbial. Infect."},{"key":"10.1016\/j.ejmech.2018.08.061_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/acs.jmedchem.7b01300","article-title":"Novel terminal bipheny-based diapophytoene desaturases (CrtN) inhibitors as anti-MRSA\/VISR\/LRSA agents with reduced hERG activity","volume":"61","author":"Li","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib4","first-page":"204","volume":"18","author":"Koyama","year":"2013","journal-title":"Anti-Infectious Agents against MRSA. Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib5","doi-asserted-by":"crossref","first-page":"17888","DOI":"10.1074\/jbc.M313123200","article-title":"On the transcriptional regulation of methicillin resistance: MecI repressor in complex with its operator","volume":"279","author":"Garria-Castellanos","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib6","doi-asserted-by":"crossref","first-page":"18283","DOI":"10.3390\/molecules191118283","article-title":"Curcumin reverse methicillin resistance in Satphylococcus aureus","volume":"19","author":"Mun","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2018.02.031","article-title":"Alkynyl-containing phenylthiazoles: systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"148","author":"Elsebaei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib8","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/15680266113139990133","article-title":"Insight view on possible role of fluoroquinolones in cancer therapy","volume":"13","author":"Sharma","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cclet.2016.07.024","article-title":"Synthesis and in\u00a0vitro antitumor activity of novel naphthyridinone derivatives","volume":"28","author":"Jia","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.08.061_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.04.002","article-title":"Isoniazid derivatives and their anti-tubercular activity","volume":"133","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone derivatives and their anti-tubercular activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2174\/1389557511009011046","article-title":"Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview","volume":"10","author":"Luo","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: a overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2016.10.001","article-title":"History of antimicrobial drug discovery-major classes and health impact","volume":"133","author":"Aminov","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.08.061_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram positive pathogens","volume":"144","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2174\/092986709788186156","article-title":"The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry","volume":"16","author":"Mugnaini","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib19","doi-asserted-by":"crossref","DOI":"10.2174\/2211352516666180215151216","article-title":"Recent advances of 2-Quinolone-based derivatives as anti-tubercular agents","volume":"16","author":"Liu","year":"2018","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.ejmech.2018.08.061_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bmcl.2015.12.028","article-title":"Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from citrus reticulate (blanco)","volume":"26","author":"Marie","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bioorg.2017.09.015","article-title":"Application of the morita-baylis-hillman reaction in the synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors","volume":"75","author":"Sekgota","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib22","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.bmcl.2016.03.106","article-title":"Novel Tricyclics (e.g., GSK945237) as Potent Inhibitors of Bacterial Type IIA Topoisomerases","volume":"26","author":"Miles","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib23","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.bmcl.2017.06.009","article-title":"Novel 3-Fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"27","author":"Mitton-Fry","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib24","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1021\/jm300690s","article-title":"Novel N-Linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pKa: antibacterial agents with an improved safety profile","volume":"55","author":"Reck","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib25","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bmcl.2006.12.081","article-title":"A\u00a0new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds","volume":"17","author":"Yamamoto","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1055\/s-0030-1270782","article-title":"Chemical constituents, antimicrobial and antimalarial activities of Zanthoxylum monophyllum","volume":"77","author":"Rodr\u00edguez","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2018.08.061_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.phytol.2012.03.007","article-title":"Glycopentaphyllone: the first isolation of hydroperoxyquinolone from the fruits of Glycosmis pentaphylla","volume":"5","author":"Sripisut","year":"2012","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.ejmech.2018.08.061_bib28","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/AAC.47.5.1604-1613.2003","article-title":"In\u00a0vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus","volume":"47","author":"Firsov","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib29","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dks307","article-title":"Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization","volume":"67","author":"Remy","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10156-013-0580-2","article-title":"Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections","volume":"19","author":"Tanigawara","year":"2013","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib31","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.47.12.3935-3941.2003","article-title":"Pharmacodynamics of the new des-F(6)-quinolone garenoxacin in a murine thigh infection model","volume":"47","author":"Andes","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib32","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/AAC.01197-09","article-title":"Comparative in\u00a0vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates","volume":"54","author":"Lauderdale","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib33","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/jac\/dkq341","article-title":"In\u00a0vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone","volume":"65","author":"Li","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib34","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1128\/AAC.01509-13","article-title":"In\u00a0vitro activity of ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria","volume":"57","author":"L\u03ccpez","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/49.3.455","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone","volume":"49","author":"Yamakawa","year":"2002","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jgar.2017.12.004","article-title":"Characterisation of fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus of human and pig origin","volume":"12","author":"Li","year":"2018","journal-title":"J.\u00a0Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2018.08.061_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.061_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"28","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.08.061_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmech.2017.05.004","article-title":"Recent developments of coumarin-containing derivatives and their anti-tubercular activity","volume":"136","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib40","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/AAC.46.9.3071-3074.2002","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic","volume":"46","author":"Yun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib41","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib42","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.14233\/ajchem.2014.15943","article-title":"Antibacterial activity of naphthyridone derivatives containing 8-Alkoxyimino-1,6-dizaspiro[3,4]octane scaffolds","volume":"26","author":"Feng","year":"2014","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib43","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.tet.2011.08.089","article-title":"Synthesis of naphthyridone derivatives containing 8-Alkoxyimino-1,6-dizaspiro[3.4]octane scaffolds","volume":"67","author":"Feng","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.08.061_bib44","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.bmcl.2011.04.002","article-title":"Design, synthesis and in\u00a0vitro antibacterial activity of 7-(4-Alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives","volume":"21","author":"Chai","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib45","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bmcl.2016.03.050","article-title":"Synthesis, antimycobacterial and antibacterial activity of 1-(6-Amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety","volume":"26","author":"Huang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib46","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cmdc.201200210","article-title":"Design, synthesis, and in\u00a0vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(Alkoxyimino)-2-(aminomethyl)azetidine moiety","volume":"7","author":"Lv","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.08.061_bib47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2014.09.029","article-title":"Synthesis, antimycobacterial and antibacterial evaluation of l-[(1r,2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety","volume":"86","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2012.07.010","article-title":"Synthesis and in\u00a0vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety","volume":"55","author":"Feng","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2015.09.030","article-title":"Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety","volume":"104","author":"Zhang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib50","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.bmcl.2010.07.006","article-title":"Synthesis and in\u00a0vitro antibacterial activity of quinolone\/naphthyridone derivatives containing 3-Alkoxyimino-4-(methyl)aminopiperidine scaffolds","volume":"20","author":"Chai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib51","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1016\/j.bmcl.2015.10.027","article-title":"Synthesis, antimycobacterial and antibacterial activity of l-[(1r,2S)-2-fluorocyclopropyl]naphthyridone derivatives containing an oxime-functionalized pyrrolidine moiety","volume":"25","author":"Huang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ardp.200900191","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(3-Alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-Fluoroquinolone derivatives","volume":"343","author":"Zhang","year":"2010","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib53","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/j.ejmech.2010.08.050","article-title":"Synthesis and in\u00a0vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N\u2019-Alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines","volume":"45","author":"Guo","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib54","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.3390\/molecules19056822","article-title":"Synthesis and antibacterial activity of amino acid and dipeptide prodrugs of IMB-070593, a fluoroquinolone candidate","volume":"19","author":"Zhang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib55","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.3390\/molecules18043872","article-title":"Synthesis, in\u00a0vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety","volume":"18","author":"Wei","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib56","first-page":"819","article-title":"Synthesis and antibacterial activity of 7-(3-Amino-4-alkoxyimino-1-piperidyl)quinolones","volume":"43","author":"Wang","year":"2008","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2018.08.061_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bmcl.2010.12.073","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(3-Alkoxyimino-5-amino\/methylaminopiperidin-1-yl)fluoroquinolone derivatives","volume":"21","author":"Zhang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib58","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.bmcl.2013.01.048","article-title":"Synthesis and in\u00a0vitro antibacterial activity of quinolone\/naphthyridone derivatives containing 3-Alkoxyimino-4-(methyl)aminopiperidine scaffolds","volume":"23","author":"Lv","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib59","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1016\/j.ejmech.2009.04.041","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(4-Alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives","volume":"44","author":"Chai","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib60","first-page":"819","article-title":"Synthesis and antibacterial activity of 7-(3-Amino-4-alkoxyimino-1-piperidyl)quinolones","volume":"43","author":"Wang","year":"2008","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2018.08.061_bib61","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.ejmech.2011.03.026","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(3-Alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives","volume":"46","author":"Wang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib62","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.ejmech.2011.06.032","article-title":"Synthesis and in\u00a0vitro antibacterial activity of a series of novel gatifloxacin derivatives","volume":"46","author":"Chai","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib63","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ejmech.2006.12.034","article-title":"Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring","volume":"42","author":"Foroumadi","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib64","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1021\/jm0100335","article-title":"Synthesis and antibacterial evaluation of certain quinolone derivatives","volume":"44","author":"Chen","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib65","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1021\/jm000153x","article-title":"Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives","volume":"43","author":"Fang","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","article-title":"Recent advances of imidazole-containing derivatives as anti-tubercular agents","volume":"150","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib69","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ardp.201000160","article-title":"Synthesis and in-vitro antibacterial activity of 7-(3-Aminopyrrolo[3,4-c]pyrazol-5(2H, 4H, 6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives","volume":"344","author":"Guo","year":"2011","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib70","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/molecules16032626","article-title":"Synthesis and in\u00a0vitro antibacterial activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H- pyrazolo[4,3-c]Pyridin-5(4H)-yl)fluoroquinolone derivatives","volume":"16","author":"Guo","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib71","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cclet.2010.06.011","article-title":"Synthesis and in\u00a0vitro antibacterial activities of 7-(3-Aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)quinolone derivatives","volume":"21","author":"Guo","year":"2010","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.08.061_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cbdd.12395","article-title":"Design, synthesis, antibacterial evaluation and docking study of novel 2-Hydroxy-3(nitroimidazolyl)-propyl-derived quinolone","volume":"85","author":"Li","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.08.061_bib73","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cbdd.12532","article-title":"Design, synthesis and antimicrobial evaluation of novel quinolone imidazoles and interactions with MRSA DNA","volume":"86","author":"Zhang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.08.061_bib74","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2015.06.041","article-title":"Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu2+ mediated DNA-targeting antibacterial agents","volume":"25","author":"Zhang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib75","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2014.08.063","article-title":"Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin","volume":"86","author":"Cui","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib76","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/molecules22071171","article-title":"Synthesis and in\u00a0vitro antimycobacterial and antibacterial activity of 8-OMe ciprofloxacin-hydrozone\/azole hybrids","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib77","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib78","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2018.08.061_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11030-017-9795-y","article-title":"Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity","volume":"22","author":"Dileep","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2018.08.061_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2015.04.058","article-title":"Search for factors affecting antibacterial activity and toxicity of 1,2,4-Triazole-ciprofloxacin hybrids","volume":"97","author":"Plech","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in\u00a0vitro activity of 1,2,4-Triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib83","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/molecules20046254","article-title":"Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids","volume":"20","author":"Plech","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib84","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4155\/fmc-2017-0108","article-title":"Antimicrobial 2-aminothiazolyl quinolones: what is their potential in the clinic?","volume":"9","author":"Gao","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib85","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1021\/jm500462x","article-title":"Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099)","volume":"57","author":"Basarab","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib86","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism","volume":"59","author":"Cui","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib87","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejmech.2016.10.011","article-title":"Multi-targeting exploration of new 2-aminothiazolyl quinolones: synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells","volume":"124","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700029","article-title":"Synthesis and evaluation of thiazolidine amide and N-Thiazolyl amide fluoroquinolone derivatives","volume":"350","author":"Garza","year":"2017","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib89","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bmcl.2005.11.065","article-title":"Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in\u00a0vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells","volume":"16","author":"Wiles","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib90","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/jm101604v","article-title":"Exploration of the activity of 7-Pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"54","author":"Kim","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/jm060844e","article-title":"Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at 6-, 7- and 8-positions","volume":"50","author":"Wang","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib92","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/AAC.00092-12","article-title":"Bactericidal activity of ACH-702 against nondividing and biofilm staphylococci","volume":"56","author":"Podos","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib93","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bmcl.2005.11.064","article-title":"Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at 7-position: in\u00a0vitro Activity of A Series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus","volume":"16","author":"Wiles","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4265\/bio.8.159","article-title":"Activities of novel new quinolone compounds against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus and their synergism with several commercial antibiotics","volume":"8","author":"Sakagami","year":"2003","journal-title":"Biocontrol Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4265\/bio.13.103","article-title":"Anti-vre and anti-MRSA activities of new quinolones and their synergism with commercial antibiotics. Part 2","volume":"13","author":"Sakagami","year":"2008","journal-title":"Biocontrol Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib96","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bmcl.2013.03.118","article-title":"Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA","volume":"23","author":"Cui","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib97","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1021\/jm980693i","article-title":"6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3","volume":"42","author":"Tarantino","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib98","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/jm0510023","article-title":"Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors","volume":"49","author":"Zhi","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.01311-05","article-title":"Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound","volume":"51","author":"Butler","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/jhet.3189","article-title":"Isatin derivatives with potential anti-tubercular activities","author":"Jiang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib101","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1248\/cpb.55.894","article-title":"Synthesis and antibacterial activity of new N-[2-(Thiophen-3-yl)ethyl]Piperazinyl quinolones","volume":"55","author":"Letafat","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.08.061_bib102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ardp.200600169","article-title":"Synthesis and antibacterial activity of new 7-piperazinylquinolones containing a functionalized 2-(Furan-3-yl)ethyl moiety","volume":"340","author":"Foroumadi","year":"2007","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ardp.200700090","article-title":"Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety","volume":"341","author":"Emami","year":"2008","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2018.08.061_bib104","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7164\/antibiotics.51.857","article-title":"Preparation and antimicrobial assessment of 2-Thioether-linked quinolonyl-carbapenems","volume":"51","author":"Hershberger","year":"1998","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2018.08.061_bib105","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.6b00485","article-title":"Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections","volume":"59","author":"Ma","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib106","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/jm900028n","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics","volume":"52","author":"Pokrovskaya","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib107","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0960-894X(03)00208-7","article-title":"Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus","volume":"13","author":"Kerns","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib108","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0960-894X(03)00376-7","article-title":"Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus","volume":"13","author":"Kerns","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib109","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1016\/j.ejmech.2011.10.014","volume":"46","author":"Az\u00e9ma","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2011.10.049","article-title":"Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials","volume":"47","author":"McPherson","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib111","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1021\/jm0105326","article-title":"Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials","volume":"45","author":"Herczegh","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib112","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib113","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/jm990015b","article-title":"Glycosylation of fluoroquinolones through direct and oxygenated polymethylene linkages as a sugar-mediated active transport system for antimicrobials","volume":"42","author":"Jung","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib114","first-page":"332","article-title":"Design, synthesis, antibacterial, anti-cell proliferation activities of [1,2,4]-Triazino[3,4-h][1,8]naphthyridine-8-one-7-carboxylic acid derivatives","volume":"50","author":"Gao","year":"2014","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2018.08.061_bib115","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.3390\/molecules18077557","article-title":"New 7-[4-(4-(un)Substituted)piperazine-1-Carbonyl-piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation","volume":"18","author":"Chen","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib116","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bmcl.2009.01.007","article-title":"Synthesis of citrate-ciprofloxacin conjugates","volume":"19","author":"Md-Saleh","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib117","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1039\/c3ob40162f","article-title":"Staphyloferrin a as siderophore-component in fluoroquinolone-based Trojan horse antibiotics","volume":"21","author":"Milner","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib118","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00044-013-0873-0","article-title":"New azetidine-3-carbonyl-N-methyl-hydrazino derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties","volume":"23","author":"Rajulu","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.061_bib119","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.3390\/molecules22060957","article-title":"Synthesis and evaluation of antimicrobial activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q conjugates","volume":"22","author":"Riahifard","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15257770902736442","article-title":"Synthesis of zidovudine derivatives with anti-HIV-1 and antibacterial activities","volume":"28","author":"Senthilkumar","year":"2009","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2018.08.061_bib121","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmcl.2012.05.026","article-title":"Study on the antibacterial properities of N-Acylated ciprofloxacins","volume":"22","author":"Cormier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/157340610791321442","article-title":"Design of ciprofloxacin derivatives that inhibit growth of methicillin resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA)","volume":"6","author":"Bartzatt","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib123","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ejmech.2011.01.044","article-title":"Synthesis and antibacterial evaluation of novel 8-fluoro norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus","volume":"46","author":"Sunduru","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib124","first-page":"58","article-title":"Synthesis and antibacterial activity of dl-7-(4,4-dimethyl-3-aminomethylpyrrolidinyl)quinolones","volume":"41","author":"Wang","year":"2006","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2018.08.061_bib125","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1016\/j.bmcl.2016.10.002","article-title":"Allicin-inspired thiolated fluoroquinolones as antibacterials against ESKAPE pathogens","volume":"26","author":"Sheppard","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib126","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/jac\/dkr203","article-title":"Interaction of N-Methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics","volume":"66","author":"Guzman","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ptr.4987","article-title":"Quinolone alkaloids from fructus euodiae show activity against methicillin-resistant Staphylococcus aureus","volume":"28","author":"Pan","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2018.08.061_bib128","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.3390\/molecules17078217","article-title":"Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl\/(E)-alkenyl-4-(1H)-quinolones","volume":"17","author":"Wube","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.061_bib129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1248\/cpb.56.346","article-title":"Synthesis of new quinolone antibiotics ulterlizing azetidine derivatives obtained from 1-azabicyclo[1.1.0]butane","volume":"56","author":"Ikee","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.08.061_bib130","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bmcl.2006.11.048","article-title":"Synthesis and antibacterial activities of new quinolone derivatives ulterlizing 1-azabicyclo[1.1.0]butane","volume":"17","author":"Ikee","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib131","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/jm0205090","article-title":"A\u00a0novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-Amino-2,4-difluorophenyl) group","volume":"45","author":"Kuramoto","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib132","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2014.07.017","article-title":"In\u00a0vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens","volume":"44","author":"Kazamori","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2018.08.061_bib133","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1128\/AAC.47.12.3750-3759.2003","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DK-507k, a novel fluoroquinone","volume":"47","author":"Otani","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib134","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/jm301650g","article-title":"Design, synthesis, and biological evaluations of novel 7-[7-Amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potential antibacterial activity against respiratory pathogens","volume":"56","author":"Odagiri","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/AAC.00853-07","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DC-159a, a new fluoroquinolone","volume":"52","author":"Hoshino","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib136","first-page":"3034","article-title":"In\u00a0vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone","volume":"49","author":"Fujikawa","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib137","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.01223-06","article-title":"Lack of effect of DX-619, a novel des-fluoro(6) quinolone, on glomerular filtration rate measured by serum clearance of","volume":"51","author":"Sarapa","year":"2007","journal-title":"Cold Iohexol. Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib138","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1128\/AAC.00847-06","article-title":"Molecular characteristics and in\u00a0vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of panton-valntine leucocidin-positive multidrug-resistant Staphylococcus aureus isolates from the community and hospital","volume":"50","author":"Yamamato","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib139","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/AAC.46.4.1119-1121.2002","article-title":"Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance","volume":"46","author":"Low","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib140","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/AAC.05044-11","article-title":"Randomized, double-blind, phase II, multicentre study evaluating the safety\/tolerability and efficacy of JNJ-q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection","volume":"55","author":"Covington","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib141","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/AAC.00470-11","article-title":"Antistaphylococcal activities of the new fluoroquinolone JNJ-q2","volume":"55","author":"Morrow","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib142","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1128\/AAC.00162-11","article-title":"JNJ-Q2, a new fluoroquinolone with potent in\u00a0vitro activity against Staphylococcus aureus, including multidrug-resistant and fluoroquinolone-resistant strains","volume":"55","author":"Farrell","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib143","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1016\/j.bmcl.2014.10.014","article-title":"7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors","volume":"24","author":"Grant","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib144","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1128\/AAC.48.12.4754-4761.2004","article-title":"Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models","volume":"48","author":"Patel","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.061_bib145","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1016\/j.bmcl.2015.07.044","article-title":"Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens","volume":"25","author":"Huang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.061_bib146","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/jm050035f","article-title":"A\u00a0chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus","volume":"48","author":"de Souza","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.061_bib147","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1128\/AAC.47.12.3694-3698.2003","article-title":"Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-Caused hematogenous pulmonary infections in mice","volume":"47","author":"Kaneko","year":"2003","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:57:08Z","timestamp":1759327028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418307311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":147,"alternative-id":["S0223523418307311"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.061","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}